- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Statins Have Heart Benefits Beyond Lowering Cholesterol
While statins are primarily used to lower cholesterol, they are also associated with improved heart structure and function, according to research presented at EuroCMR 2017, which was held by the European Society of Cardiology, May 25-27, in Prague, Czech Republic.
While statins are primarily used to lower cholesterol, they are also associated with improved heart structure and function, according to research presented at EuroCMR 2017, which was held by the European Society of Cardiology, May 25-27, in Prague, Czech Republic.
According to the study’s lead author, Dr Nay Aung of Queen Mary University in London, United Kingdom, statins are also “highly effective in preventing cardiovascular events in patients who have had a heart attack or are at risk of heart disease.”
Small studies in humans have shown that statins reduce the thickness of the heart muscle and also improve the function of blood vessels, reduce inflammation, and stabilize fatty plaques in the blood vessels.
The study of 4622 people without cardiovascular disease assessed the relationship between statin use and heart structure and function. Nearly 17% of the participants were taking statins and they were more likely to be older, have higher body mass index and blood pressure, and have diabetes and hypertension.
“People using statins were less likely to have a thickened heart muscle (left ventricular hypertrophy) and less likely to have a large heart chamber,” Aung said in a statement. “Having a thick, large heart is a strong predictor of future heart attack, heart failure or stroke and taking statins appears to reverse the negative changes in the heart which, in turn, could lower the risk of adverse outcomes.”
However, the people taking statins were still at a higher risk of having heart problems compared with people not taking statins. While there are benefits beyond lowering cholesterol, statin prescribers should still identify people who will benefit the most from them.
“That means looking at not only clinical risk factors such as smoking and high blood pressure, but also genetic (hereditary) factors which can predict individuals’ response to statins,” Aung said. “This is an area of growing interest and one that we are also investigating in our lab with our collaborators.”
Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
March 14th 2025Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they are not cost-effective at their current prices, according to a new evaluation, placing economic burdens on patients with obesity in the US.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
